Frontiers in Oncology | Neuro-Oncology and Neurosurgical Oncology

Correction

Published on 01 Feb 2024

Corrigendum: Bevacizumab-Irinotecan combination therapy in recurrent low-grade glioma, previously treated with chemo-radiotherapy: a case report

in Neuro-Oncology and Neurosurgical Oncology

Barbara Castelli
Carla Fonte
Milena Guidi
Marco Tellini
Marco Di Nicola
Alessandro Iacono
Anna Maria Buccoliero
Daniela Greto
Lorenzo Genitori
Iacopo Sardi

Frontiers in Oncology

doi 10.3389/fonc.2024.1372295

1,212 views

Original Research

Published on 31 Jan 2024

Epigenetic modification and characterization of the MGMT promoter region using CRISPRoff in glioblastoma cells

in Neuro-Oncology and Neurosurgical Oncology

Remi Weber
Michael Weller
Guido Reifenberger
Flavio Vasella

Frontiers in Oncology

doi 10.3389/fonc.2024.1342114

2,241 views
2 citations

Original Research

Published on 30 Jan 2024

Enhancing the referral process for surgical management of spinal metastases: insights from a 12-year, bi-institutional study of 533 patients

in Neuro-Oncology and Neurosurgical Oncology

Bertrand Debono
Alexis Perez
Guillaume Lonjon
Olivier Hamel
Jean-Baptiste Dandine
Martin Dupuy
Guillaume Dutertre
Cécile Braticevic
Igor Latorzeff
Aymeric Amelot

Frontiers in Oncology

doi 10.3389/fonc.2024.1301305

1,198 views

Original Research

Published on 29 Jan 2024

Robotic stereotactic radiosurgery for intracranial meningiomas in elderly patients: assessment of treatment efficacy and safety

in Neuro-Oncology and Neurosurgical Oncology

Anton Früh
Bohdan Bodnar
Marcel Nachbar
Julia Gradhand
Goda Kalinauskaite
Kerstin Rubarth
Peter Truckenmueller
David Kaul
Daniel Zips
Peter Vajkoczy

Frontiers in Oncology

doi 10.3389/fonc.2024.1329696

1,552 views
2 citations

Case Report

Published on 24 Jan 2024

Case report: Unilateral paralysis of the hypoglossal nerve as the only clinical sign of clivus meningioma - a case report and literature review

in Neuro-Oncology and Neurosurgical Oncology

Jelena Stamenović
Biljana Živadinović
Vanja Đurić

Frontiers in Oncology

doi 10.3389/fonc.2024.1337680

1,339 views

Original Research

Published on 23 Jan 2024

MAPK-activated protein kinase 2 is associated with poor prognosis of glioma patients and immune inhibition in glioma

in Neuro-Oncology and Neurosurgical Oncology

Jinmin Sun
Sicheng Wu
Wenyu Zhao
Senrui Xue
Lei Zhang
Jing Ren

Frontiers in Oncology

doi 10.3389/fonc.2024.1307992

1,909 views
2 citations

Mini Review

Published on 23 Jan 2024

Sex-specific molecular differences in glioblastoma: assessing the clinical significance of genetic variants

in Neuro-Oncology and Neurosurgical Oncology

Nicolina Jovanovich
Ahmed Habib
Akanksha Chilukuri
N. U. Farrukh Hameed
Hansen Deng
Regan Shanahan
Jeffrey R. Head
Pascal O. Zinn

Frontiers in Oncology

doi 10.3389/fonc.2023.1340386

4,133 views
7 citations

Case Report

Published on 19 Jan 2024

Primary central nervous system post-transplant lymphoproliferative disorder after allogeneic stem cell transplantation: a case report

in Neuro-Oncology and Neurosurgical Oncology

Margaret Tugend
Jordan Dattero
Tsiporah Shore
Vladislav Korobeynikov
Raymond F. Sekula

Frontiers in Oncology

doi 10.3389/fonc.2024.1284577

1,803 views
2 citations

Original Research

Published on 16 Jan 2024

Risk-benefit analysis of surgical treatment strategies for cystic craniopharyngioma in children and adolescents

in Neuro-Oncology and Neurosurgical Oncology

Michael Schmutzer-Sondergeld
Stefanie Quach
Sebastian Niedermeyer
Nico Teske
Moritz Ueberschaer
Christian Schichor
Mathias Kunz
Niklas Thon

Frontiers in Oncology

doi 10.3389/fonc.2024.1274705

1,745 views
3 citations

Original Research

Published on 15 Jan 2024

Potent in vivo efficacy of oral gallium maltolate in treatment-resistant glioblastoma

in Neuro-Oncology and Neurosurgical Oncology

Mona M. Al-Gizawiy
Robert T. Wujek
Hisham S. Alhajala
Jonathan M. Cobb
Melissa A. Prah
Ninh B. Doan
Jennifer M. Connelly
Christopher R. Chitambar
Kathleen M. Schmainda

Frontiers in Oncology

doi 10.3389/fonc.2023.1278157

3,710 views
3 citations

Systematic Review

Published on 12 Jan 2024

Emerging trends and thematic evolution of immunotherapy for glioma based on the top 100 cited articles

in Neuro-Oncology and Neurosurgical Oncology

Yan Zhou
Min Liu
Xing Huang
Zhen Liu
Yun Sun
Minjie Wang
Tao Huang
Xianke Wang
Long Chen
Xiaobing Jiang

Frontiers in Oncology

doi 10.3389/fonc.2023.1307924

2,881 views
4 citations

Case Report

Published on 12 Jan 2024

Case report: meningeal lymphangiogenesis around ependymoma forming along the dura matter

in Neuro-Oncology and Neurosurgical Oncology

Utaro Hino
Ryota Tamura
Masahiro Yo
Yoshitaka Kase
Noboru Tsuda
Tsubasa Miyauchi
Junki Sogano
Kosuke Karatsu
Tomoru Miwa
Masahiro Toda

Frontiers in Oncology

doi 10.3389/fonc.2023.1340167

1,505 views

Opinion

Published on 11 Jan 2024

Vorasidenib in IDH1/2-mutant low-grade glioma: the grey zone of patient’s selection

in Neuro-Oncology and Neurosurgical Oncology

Lidia Gatto
Vincenzo Di Nunno
Alicia Tosoni
Stefania Bartolini
Lucia Ranieri
Enrico Franceschi

Frontiers in Oncology

doi 10.3389/fonc.2023.1339266

4,437 views

Original Research

Published on 10 Jan 2024

Enhancing outcomes: neurosurgical resection in brain metastasis patients with poor Karnofsky performance score - a comprehensive survival analysis

in Neuro-Oncology and Neurosurgical Oncology

Maria Goldberg
Michel G. Mondragon-Soto
Ghaith Altawalbeh
Lea Baumgart
Jens Gempt
Denise Bernhardt
Stephanie E. Combs
Bernhard Meyer
Amir Kaywan Aftahy

Frontiers in Oncology

doi 10.3389/fonc.2023.1343500

1,719 views
5 citations

Review

Published on 10 Jan 2024

Long-term response to sequential anti-HER2 therapies including trastuzumab-deruxtecan in a patient with HER2-positive metastatic breast cancer with leptomeningeal metastases: a case report and review of the literature

in Neuro-Oncology and Neurosurgical Oncology

Axel de Bernardi
Thomas Bachelot
Louis Larrouquère

Frontiers in Oncology

doi 10.3389/fonc.2023.1210873

3,138 views
3 citations

Systematic Review

Published on 10 Jan 2024

Comparing [18F]FET PET and [18F]FDOPA PET for glioma recurrence diagnosis: a systematic review and meta-analysis

in Neuro-Oncology and Neurosurgical Oncology

Pengbo Yu
Yinan Wang
Fengbo Su
Yan Chen

Frontiers in Oncology

doi 10.3389/fonc.2023.1346951

2,029 views
2 citations